Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa

BACKGROUND: Tuberculosis remains the leading cause of death in South Africa. A number of potential new TB vaccine candidates have been identified and are currently in clinical trials. One such candidate is MVA85A. This study aimed to estimate the cost-effectiveness of adding the MVA85A vaccine as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Channing, Liezl, Sinanovic, Edina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169661/
https://www.ncbi.nlm.nih.gov/pubmed/25242892
http://dx.doi.org/10.1186/1478-7547-12-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169661/
https://www.ncbi.nlm.nih.gov/pubmed/25242892
http://dx.doi.org/10.1186/1478-7547-12-20

Ejemplares similares